A $9 billion valuation fell to zero. The record on Theranos shows which warning signs were visible early, and what technical buyers can check before they trust a bold claim.
Share this article
Elizabeth HolmesSEC Theranos settlementSunny BalwaniTheranosTheranos fraudtechnical due diligence
Comments